OncoSec Medical Inc (ONCSQ)

[zb19812013]

Realistic future projections for PPS for ONCS ?

I rarely post. But I first bought into ONCS about 3 years ago and have accumulated here and there since then, although not lately. My average was about .50 (pre reverse split) and looking back it would have been wise to sell when it was about a dollar. I would have gladly taken that money and bought back even more shares at a cheaper price. But, I am obviously upside down now and while I think this stock has amazing potential, to say I am frustrated is an understatement. My problem has always been I either sold too soon (INO) or didn't sell at all (ONCS).

We all see some of the other biotech stocks out there that get acquired or at the very least start to make some real money licensing their products. It is frustrating to watch a stock that I believe could make huge gains for its investors (and help people who are sick as well) continue to drift downward. Now it all seems to hinge on the P2B data that we hope to get in the coming months.

Assuming the data is indeed positive, I would hope Dhillon would allow ONCS to be acquired if an offer came in. But I read that he is more interested in licensing the technology (correct me if I am wrong on that). Honestly, I would love to see him allow ONCS to be bought out, so I could get my money (and hopefully a profit), and move on.

But lets make another assumption. Lets assume more dilution would occur over the next year or two. Lets say in the next year or two, there are 25,000,000 shares out there as opposed to the current +/- 16,900,000. Do you all think it is realistic that this company would have a valuation of $500 million? That would be about a 20 dollar per share price. I do think its very possible, given that other Biotech's (see ZIOP since it has been discussed lately), have a market cap of nearly 1 billion dollars and over 100 million more outstanding shares. Now I know that no two stocks are apples to apples, but I am curious what you guys think this stock could realistically be worth in a year or two.